Ridgetech Inc. (RDGT)
RDGT trades on Nasdaq in Consumer Staples, Retail-Drug Stores and Proprietary Stores. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1856084/000121390026083638/0001213900-26-083638-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | RDGT on Nasdaq |
| Sector | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores |
| Country | China |
| IPO year | Not reported by the screener |
| SEC CIK | 0001856084 |
| SEC industry code | Retail-Drug Stores and Proprietary Stores |
| Incorporated in | Cayman Islands |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $132.2M |
| Net income | -$1.3M |
| Operating income | -$1.9M |
| Net margin | -0.9% |
| Operating margin | -1.4% |
| Revenue growth | +10.2% |
| Cash | $17.9M |
| Total assets | $69.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.0× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-07-31 |
| Cash and burn | $17.9M cash; operating cash flow -$348K a quarter. | Report 2026-03-31 |
| Shares outstanding | No cover-page share count in XBRL | Cover page 2026-03-31 |
| Reverse splits, 3 years | 2; latest 1-for-150 on 2026-04-08 | Source 2026-04-08 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-07-29 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | YCM CPA INC., Irvine, California, United States | PCAOB Form AP 2026-08-11 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $161K, sold $116K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2026 2026-03-31 | $132.2M | -$1.3M | -$1.4M | $17.9M | $23K | $132.2M | 20-F 2026-07-31 |
| FY 2025 2025-03-31 | $120.0M | $10.2M | $1.2M | $12.8M | $10.4M | $120.0M | 20-F 2026-07-31 |
| FY 2024 2024-03-31 | $124.0M | -$4.2M | -$3.2M | $2.3M | $6.9M | $124.0M | 20-F 2026-07-31 |
| FY 2023 2023-03-31 | $120.2M | -$21.1M | -$3.3M | $18.8M | $29.3M | $120.2M | 20-F 2025-07-28 |
| FY 2022 2022-03-31 | $164.4M | -$3.2M | -$5.4M | $18.5M | $36.1M | $164.4M | 20-F 2024-07-30 |
| FY 2021 2021-03-31 | $133.1M | -$8.1M | -$62K | $22.0M | $2.7M | $133.1M | 20-F 2023-06-15 |
| FY 2020 2020-03-31 | $117.3M | -$5.8M | -$6.9M | $31.0M | No debt tags | $117.3M | 20-F 2022-07-28 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-07-29 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-07-31 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-11-06 |
Source: SEC EDGAR submissions feed, 132 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +6.0% |
| 1 month | +23.3% |
| 3 months | +20.5% |
| Year to date | -99.8% |
| 1 year | -99.8% |
| From 52-week high | -99.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Retail-Drug Stores and Proprietary Stores
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PETS | PetMed Express Inc. | $0.8977 | -4.52% | $20.0M |
| YI | 111 Inc. | $2.84 | -0.35% | $25.0M |
| GRDN | Guardian Pharmacy Services Inc. | $49.43 | -0.18% | $3.1B |
| CVS | CVS Health Corporation | $88.59 | -0.85% | $113.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier